Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 438,950 shares of Geron common stock as...

Related Keywords

United States , ,Linkedin ,Geron Corporation Nasdaq ,Drug Administration ,European Union ,Geron Corporation ,Nasdaq Listing Rule ,Award Plan ,Nobel Prize Winning ,New Drug Application ,United States Food ,Prescription Drug User Fee Act ,